Prophylactic treatment of migraine by GPs: A qualitative study

British Journal of General Practice

Volumn 62, Issue 597, 2012, Pages

  Dekker, Frans ^a   Neven, Arie Knuistingh ^a   Andriesse, Boukje ^a   Kernick, David ^b   Ferrari, Michel D ^a   Assendelft, Willem J J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ROYAL COLLEGE OF GENERAL PRACTITIONERS   (United Kingdom)

Author keywords

General practice; Headache; Migraine disorders; Physician patient relations; Primary health care; Qualitative research; Secondary prevention

Indexed keywords

ANTIMIGRAINE AGENT;

ADULT; ARTICLE; DRUG DEPENDENCE; DRUG SAFETY; FEMALE; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; MALE; MEDICAL ETHICS; MIGRAINE; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRESCRIPTION; PROPHYLAXIS; QUALITATIVE RESEARCH; RISK FACTOR;

ADULT; ANALGESICS; ATTITUDE OF HEALTH PERSONNEL; FAMILY PRACTICE; FEMALE; FOCUS GROUPS; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PATIENT SATISFACTION; PERCEPTION; PHYSICIAN'S PRACTICE PATTERNS; TREATMENT OUTCOME;

EID: 84859461486     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp12X636100     Document Type: Article

References (46)

1. Goadsby PJ, Sprenger T. Current practice and future directions in the prevention and acutemanagement ofmigraine. Lancet Neurol 2010; 9(3): 285-298.
2. Dekker F,Wiendels N, de Valk V, et al. Triptan overuse in the Dutch general population: a nationwide pharmaco-epidemiology database analysis in 6.7 million people.Cephalalgia 2011; 31(8): 943-952.
3. D'Amico D, Solari A, Usai S, et al. Improvement in quality of life and activity limitations inmigraine patients after prophylaxis. A prospective longitudinal multicentre study. Cephalalgia 2006; 26(6): 691-696.
4. Ramadan NM, Schultz LL, Gilkey SJ. Migraine prophylactic drugs: proof of efficacy, utilization and cost. Cephalalgia 1997; 17(2): 73-80. (Pubitemid 27167496)
5. Silberstein SD, Winner PK, Chmiel JJ. Migraine preventive medication reduces resource utilization. Headache 2003; 43(3): 171-178. (Pubitemid 36348763)
6. Silberstein SD, Goadsby PJ. Migraine: preventive treatment. Cephalalgia 2002; 22(7): 491-512. (Pubitemid 36609343)
7. Grol MH, Neven AK, Pijnenborg L, Goudswaard AN. [Summary of the practice guideline 'Headache' fromthe Dutch College of General Practitioners]. Ned Tijdschr Geneeskd 2006; 150(6): 305-309.
8. Rahimtoola H, Buurma H, Tijssen CC, et al. Incidence and determinants of migraine prophylactic medication in the Netherlands. Eur J Clin Pharmacol 2002; 58(2): 149-155.
9. Linde M, Jonsson P, Hedenrud T. Influence of disease features on adherence to prophylactic migraine medication. Acta Neurol Scand 2008; 118(6): 367-372.
10. Mulleners WM, Chronicle EP. Anticonvulsants inmigraine prophylaxis: a Cochrane review. Cephalalgia 2008; 28(6): 585-597. (Pubitemid 351614940)
11. Victor S, Ryan SW. Drugs for preventing migraine headaches in children. Cochrane Database Syst Rev 2003; (4): CD002761.
12. Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007; 68(5): 343-349. (Pubitemid 46184209)
13. Cevoli S, D'Amico D, Martelletti P, et al. Underdiagnosis and undertreatment ofmigraine in Italy: a survey of patients attending for the first time 10 headache centres. Cephalalgia 2009; 29(12): 1285-1293.
14. Kol CM, Dekker F, Neven AK, et al. Acceptance or rejection of prophylactic medicine in patients with migraine: a cross-sectional study. Br J Gen Pract 2008; 58(547): 98-101. (Pubitemid 351222895)
15. Kuper A, Lingard L, Levinson W. Critically appraising qualitative research. BMJ 2008; 337: a1035.
16. Morgan M, Jenkins L, Ridsdale L. Patient pressure for referral for headache: a qualitative study of GPs' referral behaviour.Br J Gen Pract 2007; 57(534): 29-35. (Pubitemid 46070807)
17. Heath C, Hindmarsh J, Luff P. Video in qualitative research. London: Sage Publications, 2010.
18. Pope C, Mays N. Reaching the parts othermethods cannot reach: an introduction to qualitative methods in health and health services research. BMJ 1995; 311(6996): 42-45.
19. Pope C, Ziebland S, Mays N. Qualitative research in health care. Analysing qualitative data. BMJ 2000; 320(7227): 114-116.
20. Joffe H, Yardley L. Content and thematic analysis. In: Marks DF, Yardley L (eds.). Research methods for clinical and health psychology. London: Sage Publications, 2003: 56-68.
21. Chamberlain K, Camic P, Yardley L. Qualitative analysis of experience: grounded theory and case studies. In: Marks DF, Yardley L (eds.). Research methods for clinical and health psychology. London: Sage Publications, 2003: 69-89.
22. Lugtenberg M, Burgers JS, Westert GP. Effects of evidence-based clinical practice guidelines on quality of care: a systematic review. Qual Saf Health Care 2009; 18(5): 385-392.
23. D'Amico D, Tepper SJ. Prophylaxis ofmigraine: general principles and patient acceptance. Neuropsychiatr Dis Treat 2008; 4(6): 1155-1167.
24. Dowson AJ, Lipscombe S, Sender J, et al. New guidelines for the management ofmigraine in primary care.Curr Med Res Opin 2002; 18(7): 414-439. (Pubitemid 35448539)
25. Evers S, Afra J, Frese A, et al. EFNS guideline on the drug treatment of migraine-report of an EFNS task force. Eur J Neurol 2006; 13(6): 560-572. (Pubitemid 43873628)
26. Lewis D, Ashwal S, Hershey A, et al. Practice parameter: pharmacological treatment ofmigraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society.Neurology 2004; 63(12): 2215-2224. (Pubitemid 40024327)
27. Modi S, Lowder DM. Medications formigraine prophylaxis. Am Fam Physician 2006; 73(1): 72-78.
28. Pryse-Phillips WE, Dodick DW, Edmeads JG, et al. Guidelines for the diagnosis and management of migraine in clinical practice. Canadian Headache Society. CMAJ 1997; 156(9): 1273-1287. (Pubitemid 27223150)
29. Tepper SJ, D'Amico D, Baos V, et al. Guidelines for prescribing prophylactic medications for migraine: a survey among headache specialist physicians in different countries. Headache Care 2004; 1(4): 267-272.
30. Dekker F, Knuistingh Neven A, Andriesse B, et al. Prophylactic treatment of migraine; the patient's view, a qualitative study. BMC Fam Pract 2012; in press.
31. Weiner SJ, Schwartz A, Weaver F, et al. Contextual errors and failures in individualizing patient care: a multicenter study. Ann Intern Med 2010; 153(2): 69-75.
32. Peters M, Abu-Saad HH, Vydelingum V, et al. Migraine and chronic daily headache management: a qualitative study of patients' perceptions. Scand J Caring Sci 2004; 18(3): 294-303. (Pubitemid 41710689)
33. Peters M, Huijer Abu-Saad H, Vydelingum V, et al. The patients' perceptions of migraine and chronic daily headache: a qualitative study. J Headache Pain 2005; 6(1): 40-47. (Pubitemid 40277270)
34. BelamJ, Harris G, Kernick D, et al. A qualitative study of migraine involving patient researchers.Br J Gen Pract 2005; 55(511): 87-93. (Pubitemid 40246920)
35. Cottrell CK, Drew JB, Waller SE, et al. Perceptions and needs of patients with migraine: a focus group study. J Fam Pract 2002; 51(2): 142-147. (Pubitemid 34132626)
36. Peters M, Abu-Saad HH, Vydelingum V, et al. Patients' decision-making for migraine and chronic daily headache management. A qualitative study. Cephalalgia 2003; 23(8): 833-841. (Pubitemid 37255426)
37. Ivers H, McGrath PJ, Purdy RA, et al. Decision making inmigraine patients taking sumatriptan: an exploratory study. Headache 2000; 40(2): 129-136. (Pubitemid 30132053)
38. Meyer GA. The art of watching out: vigilance in women who havemigraine headaches.Qual Health Res 2002; 12(9): 1220-1234.
39. Tenhunen K, Elander J. A qualitative analysis of psychological processes mediating quality of life impairments in chronic daily headache. J Health Psychol 2005; 10(3): 397-407. (Pubitemid 40754926)
40. Ruiz de Velasco I, González N, Etxeberria Y, Garcia-Monco JC. Quality of life in migraine patients: a qualitative study. Cephalalgia 2003; 23(9): 892-900. (Pubitemid 37352626)
41. Moloney MF, Strickland OL, DeRossett SE, et al. The experiences of midlife women with migraines. J Nurs Scholarsh 2006; 38(3): 278-285. (Pubitemid 44252883)
42. Rozen TD. Migraine prevention: what patients want frommedication and their physicians (a headache specialty clinic perspective). Headache 2006; 46(5): 750-753.
43. Kowacs PA, Piovesan EJ, Tepper SJ. Rejection and acceptance of possible side effects of migraine prophylactic drugs. Headache 2009; 49(7): 1022-1027.
44. Ducros A, Romatet S, Saint MT, Allaf B. Use of antimigraine treatments by general practitioners. Headache 2011; 51(7): 1122-1131.
45. Lipton RB, Stewart WF. Acute migraine therapy: do doctors understand what patients with migraine want from therapy? Headache 1999; 39(suppl 2): S20-S26. (Pubitemid 30002025)
46. Valade D, Lanteri-Minet M, Radat F, et al. Clinical determinants of migraine preventive treatment: contribution of SMILE, an observational survey of primary care migraine management in France. Cephalalgia 2010; 30(10): 1207-1213.